Guidelines for the prescription of standard hematology and biochemistry clinical laboratory tests in the intensive care unit: A scoping review protocol.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 07 02 2024
accepted: 21 08 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

This scoping review protocol describes the strategy for a scoping review that aims to provide a comprehensive overview of published guidelines for the prescription of standard laboratory tests performed in intensive care unit (ICU) patients. The use of clinical laboratories is constantly increasing. However, there is evidence of inappropriate use. Inappropriate laboratory testing has the potential to harm patients, increase costs, burden staff, and has an environmental impact. Effective management can be achieved through demand managing strategies, such as providing guidelines on performing the appropriate test, for the right patient, at the right time. Although national and international guidelines exist for individual tests, a comprehensive summary of available recommendations for laboratory testing in the ICU is currently unavailable. This scoping review will incorporate documents that provide explicit advice on which test to perform in ICU patients. We selected 34 tests routinely ordered in the ICU. This review will consider any document type that matches our concept and context. We will consider gray literature with appropriate adherence to guidelines methodology. We will not limit the review by geographical location, but will only include articles published in English. Our scoping review will follow the Joanna Brigg Institute (JBI) methodology. We will search Medline (PubMed), Embase, Scopus, Google Scholar, and Google. Our search strategy adheres to the JBI 3-step construction approach for systematic reviews. We will search for keywords related to guidelines, laboratory testing, and the 34 selected tests. We will report our study using the S1 Checklist. Review registration number: osf.io/yfs9z.

Sections du résumé

OBJECTIVE OBJECTIVE
This scoping review protocol describes the strategy for a scoping review that aims to provide a comprehensive overview of published guidelines for the prescription of standard laboratory tests performed in intensive care unit (ICU) patients.
BACKGROUND BACKGROUND
The use of clinical laboratories is constantly increasing. However, there is evidence of inappropriate use. Inappropriate laboratory testing has the potential to harm patients, increase costs, burden staff, and has an environmental impact. Effective management can be achieved through demand managing strategies, such as providing guidelines on performing the appropriate test, for the right patient, at the right time. Although national and international guidelines exist for individual tests, a comprehensive summary of available recommendations for laboratory testing in the ICU is currently unavailable.
INCLUSION CRITERIA METHODS
This scoping review will incorporate documents that provide explicit advice on which test to perform in ICU patients. We selected 34 tests routinely ordered in the ICU. This review will consider any document type that matches our concept and context. We will consider gray literature with appropriate adherence to guidelines methodology. We will not limit the review by geographical location, but will only include articles published in English.
SEARCH STRATEGY METHODS
Our scoping review will follow the Joanna Brigg Institute (JBI) methodology. We will search Medline (PubMed), Embase, Scopus, Google Scholar, and Google. Our search strategy adheres to the JBI 3-step construction approach for systematic reviews. We will search for keywords related to guidelines, laboratory testing, and the 34 selected tests. We will report our study using the S1 Checklist. Review registration number: osf.io/yfs9z.

Identifiants

pubmed: 39453940
doi: 10.1371/journal.pone.0310059
pii: PONE-D-24-01840
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0310059

Informations de copyright

Copyright: © 2024 Devis et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Auteurs

Luigi L Devis (LL)

Biochemistry, Department of Laboratory Medicine, CHU UCL Namur, UCLouvain, Belgium.

Emilie Catry (E)

Biochemistry, Department of Laboratory Medicine, CHU UCL Namur, UCLouvain, Belgium.
Institute for Experimental and Clinical Research (IREC), UCLouvain, Belgium.

Michael Hardy (M)

Institute for Experimental and Clinical Research (IREC), UCLouvain, Belgium.
Hematology, Department of Laboratory Medicine, CHU UCL Namur, UCLouvain, Belgium.
Department of Anesthesiology, CHU UCL Namur, UCLouvain, Belgium.
Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, UCLouvain, Belgium.

Alexandre Mansour (A)

Department of Anesthesia and Critical Care, Pontchaillou University Hospital of Rennes, Rennes, France.
IRSET INSERM 1085, Univ Rennes, Rennes, France.

Patrick M Honore (PM)

Department of Intensive Care, CHU UCL Namur, UCLouvain, Belgium.

Giuseppe Lippi (G)

Section of Clinical Biochemistry and School of Medicine, University Hospital of Verona, Verona, Italy.

Mélanie Closset (M)

Biochemistry, Department of Laboratory Medicine, CHU UCL Namur, UCLouvain, Belgium.

François Mullier (F)

Institute for Experimental and Clinical Research (IREC), UCLouvain, Belgium.
Hematology, Department of Laboratory Medicine, CHU UCL Namur, UCLouvain, Belgium.
Namur Thrombosis and Hemostasis Center (NTHC), Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, UCLouvain, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH